LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.22 | 84.90 | 1121 | 9343 | 0.1200 | 0.4630 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 74.22 | 84.90 | 1146 | 9343 | 0.1227 | 0.4678 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.93 | 84.90 | 1413 | 8970 | 0.1575 | 0.5193 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.93 | 84.90 | 1436 | 8970 | 0.1601 | 0.5230 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.93 | 84.90 | 1149 | 8970 | 0.1281 | 0.4733 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.93 | 84.90 | 1171 | 8970 | 0.1305 | 0.4774 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 77.64 | 84.90 | 1416 | 9245 | 0.1532 | 0.5157 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 77.64 | 84.90 | 1446 | 9245 | 0.1564 | 0.5204 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 77.64 | 84.90 | 1130 | 9245 | 0.1222 | 0.4660 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 77.64 | 84.90 | 1157 | 9245 | 0.1251 | 0.4711 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 79.34 | 84.90 | 1439 | 9051 | 0.1590 | 0.5222 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 79.34 | 84.90 | 1469 | 9051 | 0.1623 | 0.5269 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 79.34 | 84.90 | 1148 | 9051 | 0.1268 | 0.4720 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 79.34 | 84.90 | 1178 | 9051 | 0.1301 | 0.4776 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 81.05 | 84.90 | 1459 | 8863 | 0.1646 | 0.5282 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 81.05 | 84.90 | 1491 | 8863 | 0.1682 | 0.5332 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 81.05 | 84.90 | 1146 | 8863 | 0.1293 | 0.4742 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 81.05 | 84.90 | 1172 | 8863 | 0.1322 | 0.4791 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.75 | 84.90 | 1457 | 8621 | 0.1690 | 0.5318 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.75 | 84.90 | 1493 | 8621 | 0.1732 | 0.5374 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.75 | 84.90 | 1161 | 8621 | 0.1347 | 0.4805 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.75 | 84.90 | 1183 | 8621 | 0.1372 | 0.4847 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.45 | 84.90 | 1465 | 8254 | 0.1775 | 0.5393 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.45 | 84.90 | 1502 | 8254 | 0.1820 | 0.5451 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.45 | 84.90 | 1163 | 8254 | 0.1409 | 0.4864 | MN20160318_Q02 | F10 |